Repurposing of N-Acetylcysteine for the Treatment of Dengue Virus-Induced Acute Liver Failure

Gebrehiwot Gebremedhin Tafere, Dawit Zewdu Wondafrash, Filmon Beyenne Demoz Department of Pharmacology and Toxicology, School of Pharmacy, Mekelle University, Mekelle, EthiopiaCorrespondence: Gebrehiwot Gebremedhin Tafere P.O. Box: 1871, Mekelle, EthiopiaTel +251-908822323Email gebrehiwotg07@gmail.c...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Tafere GG, Wondafrash DZ, Demoz FB
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2020
Materias:
Acceso en línea:https://doaj.org/article/fa38bf51a8684854bffacfb764ddbbb5
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:fa38bf51a8684854bffacfb764ddbbb5
record_format dspace
spelling oai:doaj.org-article:fa38bf51a8684854bffacfb764ddbbb52021-12-02T11:22:39ZRepurposing of N-Acetylcysteine for the Treatment of Dengue Virus-Induced Acute Liver Failure1179-1535https://doaj.org/article/fa38bf51a8684854bffacfb764ddbbb52020-11-01T00:00:00Zhttps://www.dovepress.com/repurposing-of-n-acetylcysteine-for-the-treatment-of-dengue-virus-indu-peer-reviewed-article-HMERhttps://doaj.org/toc/1179-1535Gebrehiwot Gebremedhin Tafere, Dawit Zewdu Wondafrash, Filmon Beyenne Demoz Department of Pharmacology and Toxicology, School of Pharmacy, Mekelle University, Mekelle, EthiopiaCorrespondence: Gebrehiwot Gebremedhin Tafere P.O. Box: 1871, Mekelle, EthiopiaTel +251-908822323Email gebrehiwotg07@gmail.comAbstract: The prevalence of dengue infection-induced acute liver damage is increasing from time to time. Since it has no specific antiviral treatment in the world, people in endemic areas suffer more from dengue disorders. Thus, there is a need for searching options for the treatment of dengue-induced acute liver failure. N-acetylcysteine, which is used for the treatment of nasal congestion disorder and paracetamol overdose toxicity, could be used as a definitive therapy for dengue virus-induced acute liver disease. Therefore, this review discusses the therapeutic use of N-acetylcysteine for dengue-induced acute liver disease. Various case reports and case series showed that patients received NAC recovered from their clinical status. Additionally, a preclinical study showed that N-acetylcysteine has anti-dengue virus activity. Thus, N-acetylcysteine could be used as a definitive therapy in dengue virus-induced hepatitis. This might encourage researchers to further investigate the importance of N-acetylcysteine for dengue virus-induced hepatitis.Keywords: N-acetylcysteine, dengue virus, acute liver failureTafere GGWondafrash DZDemoz FBDove Medical Pressarticlen-acetylcysteinedengue virusacute liver failureDiseases of the digestive system. GastroenterologyRC799-869ENHepatic Medicine: Evidence and Research, Vol Volume 12, Pp 173-178 (2020)
institution DOAJ
collection DOAJ
language EN
topic n-acetylcysteine
dengue virus
acute liver failure
Diseases of the digestive system. Gastroenterology
RC799-869
spellingShingle n-acetylcysteine
dengue virus
acute liver failure
Diseases of the digestive system. Gastroenterology
RC799-869
Tafere GG
Wondafrash DZ
Demoz FB
Repurposing of N-Acetylcysteine for the Treatment of Dengue Virus-Induced Acute Liver Failure
description Gebrehiwot Gebremedhin Tafere, Dawit Zewdu Wondafrash, Filmon Beyenne Demoz Department of Pharmacology and Toxicology, School of Pharmacy, Mekelle University, Mekelle, EthiopiaCorrespondence: Gebrehiwot Gebremedhin Tafere P.O. Box: 1871, Mekelle, EthiopiaTel +251-908822323Email gebrehiwotg07@gmail.comAbstract: The prevalence of dengue infection-induced acute liver damage is increasing from time to time. Since it has no specific antiviral treatment in the world, people in endemic areas suffer more from dengue disorders. Thus, there is a need for searching options for the treatment of dengue-induced acute liver failure. N-acetylcysteine, which is used for the treatment of nasal congestion disorder and paracetamol overdose toxicity, could be used as a definitive therapy for dengue virus-induced acute liver disease. Therefore, this review discusses the therapeutic use of N-acetylcysteine for dengue-induced acute liver disease. Various case reports and case series showed that patients received NAC recovered from their clinical status. Additionally, a preclinical study showed that N-acetylcysteine has anti-dengue virus activity. Thus, N-acetylcysteine could be used as a definitive therapy in dengue virus-induced hepatitis. This might encourage researchers to further investigate the importance of N-acetylcysteine for dengue virus-induced hepatitis.Keywords: N-acetylcysteine, dengue virus, acute liver failure
format article
author Tafere GG
Wondafrash DZ
Demoz FB
author_facet Tafere GG
Wondafrash DZ
Demoz FB
author_sort Tafere GG
title Repurposing of N-Acetylcysteine for the Treatment of Dengue Virus-Induced Acute Liver Failure
title_short Repurposing of N-Acetylcysteine for the Treatment of Dengue Virus-Induced Acute Liver Failure
title_full Repurposing of N-Acetylcysteine for the Treatment of Dengue Virus-Induced Acute Liver Failure
title_fullStr Repurposing of N-Acetylcysteine for the Treatment of Dengue Virus-Induced Acute Liver Failure
title_full_unstemmed Repurposing of N-Acetylcysteine for the Treatment of Dengue Virus-Induced Acute Liver Failure
title_sort repurposing of n-acetylcysteine for the treatment of dengue virus-induced acute liver failure
publisher Dove Medical Press
publishDate 2020
url https://doaj.org/article/fa38bf51a8684854bffacfb764ddbbb5
work_keys_str_mv AT taferegg repurposingofnacetylcysteineforthetreatmentofdenguevirusinducedacuteliverfailure
AT wondafrashdz repurposingofnacetylcysteineforthetreatmentofdenguevirusinducedacuteliverfailure
AT demozfb repurposingofnacetylcysteineforthetreatmentofdenguevirusinducedacuteliverfailure
_version_ 1718395975542767616